376 related articles for article (PubMed ID: 15329918)
21. Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study.
Grundy RG; Hutton C; Middleton H; Imeson J; Pritchard J; Kelsey A; Marsden HB; Vujanic GM; Taylor RE;
Pediatr Blood Cancer; 2004 Apr; 42(4):311-9. PubMed ID: 14966826
[TBL] [Abstract][Full Text] [Related]
22. Acute toxicities associated with radiation in the second National Wilms' Tumor Study.
Thomas PR; Tefft M; D'Angio GJ; Norkool P
J Clin Oncol; 1988 Nov; 6(11):1694-8. PubMed ID: 2846791
[TBL] [Abstract][Full Text] [Related]
23. Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group.
Kalapurakal JA; Li SM; Breslow NE; Beckwith JB; Macklis R; Thomas PR; D'Angio GJ; Kim T; de Lorimier A; Kelalis P; Shochat S; Ritchey M; Haase G; Hrabovsky E; Otherson HB; Grundy P; Green DM;
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):495-9. PubMed ID: 12957262
[TBL] [Abstract][Full Text] [Related]
24. Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor.
Tournade MF; Com-Nougué C; Voûte PA; Lemerle J; de Kraker J; Delemarre JF; Burgers M; Habrand JL; Moorman CG; Bürger D
J Clin Oncol; 1993 Jun; 11(6):1014-23. PubMed ID: 8388918
[TBL] [Abstract][Full Text] [Related]
25. Significance and management of computed tomography detected pulmonary nodules: a report from the National Wilms Tumor Study Group.
Meisel JA; Guthrie KA; Breslow NE; Donaldson SS; Green DM
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):579-85. PubMed ID: 10348287
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.
Dix DB; Seibel NL; Chi YY; Khanna G; Gratias E; Anderson JR; Mullen EA; Geller JI; Kalapurakal JA; Paulino AC; Perlman EJ; Ehrlich PF; Malogolowkin M; Gastier-Foster JM; Wagner E; Grundy PE; Fernandez CV; Dome JS
J Clin Oncol; 2018 Jun; 36(16):1564-1570. PubMed ID: 29659330
[TBL] [Abstract][Full Text] [Related]
27. Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study Group.
Green DM; Breslow NE; D'Angio GJ; Malogolowkin MH; Ritchey ML; Evans AE; Beckwith JB; Perlman EJ; Shamberger RC; Peterson S; Grundy PE; Dome JS; Thomas PR; Kalapurakal JA
Pediatr Blood Cancer; 2014 Jan; 61(1):134-9. PubMed ID: 24038736
[TBL] [Abstract][Full Text] [Related]
28. From upfront nephrectomy to preoperative chemotherapy and back: a single institution experience in the treatment of Wilms tumor.
Sultan I; Masarweh M; Ismael T; Al-Hussaini M; Almousa A; Ali HM; Rodriguez-Galindo C; Ghandour K
J Pediatr Hematol Oncol; 2009 May; 31(5):333-8. PubMed ID: 19415012
[TBL] [Abstract][Full Text] [Related]
29. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
30. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study.
Grundy P; Breslow N; Green DM; Sharples K; Evans A; D'Angio GJ
J Clin Oncol; 1989 May; 7(5):638-47. PubMed ID: 2540289
[TBL] [Abstract][Full Text] [Related]
32. The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study.
D'Angio GJ; Evans A; Breslow N; Beckwith B; Bishop H; Farewell V; Goodwin W; Leape L; Palmer N; Sinks L; Sutow W; Tefft M; Wolff J
Cancer; 1981 May; 47(9):2302-11. PubMed ID: 6164480
[TBL] [Abstract][Full Text] [Related]
33. Treatment of Wilms' tumour. Current recommendations.
Mehta MP; Bastin KT; Wiersma SR
Drugs; 1991 Nov; 42(5):766-80. PubMed ID: 1723373
[TBL] [Abstract][Full Text] [Related]
34. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
[TBL] [Abstract][Full Text] [Related]
35. Repeat nephron-sparing surgery for children with bilateral Wilms tumor.
Kieran K; Williams MA; McGregor LM; Dome JS; Krasin MJ; Davidoff AM
J Pediatr Surg; 2014 Jan; 49(1):149-53. PubMed ID: 24439600
[TBL] [Abstract][Full Text] [Related]
36. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group.
Kalapurakal JA; Nan B; Norkool P; Coppes M; Perlman E; Beckwith B; Ritchey M; Breslow N; Grundy P; D'angio GJ; Green DM; Thomas PR
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1379-84. PubMed ID: 15590168
[TBL] [Abstract][Full Text] [Related]
37. Reduced therapy for Wilms' tumor: analysis of treatment results from a single institution.
Wilimas JA; Douglass EC; Lewis S; Fairclough D; Fullen G; Parham D; Kumar AP; Hustu HO; Fleming I
J Clin Oncol; 1988 Oct; 6(10):1630-5. PubMed ID: 2845012
[TBL] [Abstract][Full Text] [Related]
38. Wilms' tumor: the experience of the pediatric unit of Kasr El-Aini center of radiation oncology and nuclear medicine (NEMROCK).
Abd El-Aal HH; Habib EE; Mishrif MM
J Egypt Natl Canc Inst; 2005 Dec; 17(4):308-14. PubMed ID: 17102824
[TBL] [Abstract][Full Text] [Related]
39. Outcomes in low-risk babies treated with half-dose chemotherapy according to the Third National Wilms' Tumor Study.
Corn BW; Goldwein JW; Evans I; D'Angio GJ
J Clin Oncol; 1992 Aug; 10(8):1305-9. PubMed ID: 1321894
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for local recurrence in Wilms tumour and the potential influence of biopsy - the United Kingdom experience.
Irtan S; Jitlal M; Bate J; Powis M; Vujanic G; Kelsey A; Walker J; Mitchell C; Machin D; Pritchard-Jones K;
Eur J Cancer; 2015 Jan; 51(2):225-32. PubMed ID: 25465191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]